
Sign up to save your podcasts
Or


IDSA President Barbara Alexander, M.D., FIDSA is joined by Luciana Borio, MD, a member of the COVID-19 Advisory Board that convened during the Biden-Harris transition, to discuss the Administration’s COVID-19 strategy, vaccine production and distribution, EUA guidance for COVID-19 therapies and the importance of masking policies.
Preliminary reports indicate some COVID-19 patients may develop a so-called “post-acute COVID-19 syndrome,” in which they experience persistent symptoms after recovering from their initial illness. The syndrome appears to affect those with mild as well as moderate-to-severe disease.
In this episode, we're joined by American Thoracic Society member, Dr. Vinay Gupta and Society of Critical Care Medicine member, Dr. Meghan Lane-Fall to discuss what's currently known about the syndrome, also known as Long COVID, and the challenges it presents to both patients and clinicians.
For more information on Long COVID, visit the COVID-19 Real-Time Learning Network.
This episode is in partnership with the American Thoracic Society and the Society of Critical Care Medicine.
We discuss the emergence of SARS-CoV-2 variants in the U.S. and the impact they'll have on COVID-19 vaccines and treatments with Kathryn Edwards, MD, FIDSA of Vanderbilt University and Mirella Salvatore, MD, FIDSA with Weill Cornell Medicine.
In this episode, we explore the Theater of War production and learn how it’s being used as a tool to help frontline healthcare workers cope with the dire realities of the COVID-19 pandemic and focus on better mental health. To discuss are Theater of War Productions Artistic Director, Bryan Doerries and American College of Emergency Physician members, Dr. Diane Birnbaumer of UCLA and Dr. Jay Kaplan of Louisiana State University.
This episode is in partnership with the American College of Emergency Physicians.
IDSA President Barbara Alexander, M.D., FIDSA speaks with IDSA Senior Vice President Amanda Jezek about how ID physicians can help shape policy on issues such as AMR and physician compensation. Dr. Alexander explains that, even in the midst of COVID, it’s important to continue promoting the value of ID.
IDSA member Dr. Javeed Siddiqui of TeleMed2U and Dr. Tamaan Osbourne-Roberts with the American Academy of Family Physicians Commission on Quality and Practice join us discuss the rise of telehealth and how it can utilized to treat and care for those battling COVID-19.
This episode is in partnership with the American Academy of Family Physicians.
COVID-19 Testing Guideline Panel members Angela Caliendo, M.D., FIDSA of Brown University and Cesar Arias, M.D., FIDSA of the University of Texas discuss recent changes made to IDSA's COVID-19 Diagnostic Guidelines.
IDSA Board member John Lynch, M.D., FIDSA, & SHEA/IDSA member Erica Shenoy, M.D., FIDSA discuss how to create safe environments across medical facility departments while treating COVID-19 patients. This episode was produced in partnership with the Society for Healthcare Epidemiology of America.
How do monoclonal antibody treatments help combat COVID-19? In this episode, we discuss the latest information on monoclonal antibodies with Dr. Eric Daar of UCLA Medical Center, Dr. Alyssa Letourneau of Massachusetts General Hospital and Dr. Roger Bedimo of the VA North Texas Health Care System.
How safe and efficient are the current COVID-19 vaccine candidates? How are public health systems and health care providers preparing for vaccine administration? Buddy Creech, M.D. and Kathryn Edwards, M.D., FIDSA of Vanderbilt University and Dial Hewlett, M.D., FIDSA of the Westchester County Department of Health answer those questions and more.